ClinicalTrials.gov record
Terminated No phase listed Observational

TITAN™ Reverse Shoulder System

ClinicalTrials.gov ID: NCT02204228

Public ClinicalTrials.gov record NCT02204228. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 18, 2026, 4:07 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Post-market Clinical Follow-up Study of the TITAN™ Reverse Shoulder System Used in Primary or Revision Total Shoulder Arthroplasty

Study identification

NCT ID
NCT02204228
Recruitment status
Terminated
Study type
Observational
Phase
Not listed
Lead sponsor
Smith & Nephew, Inc.
Industry
Enrollment
151 participants

Conditions and interventions

Interventions

  • TITAN™ Reverse Shoulder System (TRS) Device

Device

Eligibility (public fields only)

Age range
21 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2014
Primary completion
Dec 13, 2023
Completion
Dec 13, 2023
Last update posted
Mar 12, 2026

2014 – 2023

United States locations

U.S. sites
7
U.S. states
5
U.S. cities
6
Facility City State ZIP Site status
University of Florida Gainesville Florida 32607
Johns Hopkins University Columbia Maryland 21044
Mississipi Bone and Joint Clinic Starkville Mississippi 39759
Active Orthopedics Glen Ridge New Jersey 07028
Westphal Orthopaedics Lancaster Pennsylvania 17601
Hospital of the University of Pennsylvania Philadelphia Pennsylvania 19104
The Rothman Institute Philadelphia Pennsylvania 19107

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02204228, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 12, 2026 · Synced May 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02204228 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →